phase i study of hpn217 in patients with r/r multiple myeloma
Published 1 year ago • 104 plays • Length 3:06Download video MP4
Download video MP3
Similar videos
-
2:29
phase i first-in-human study of alnuctamab in patients with r/r multiple myeloma
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
3:30
phase i study of tnb-383b in r/r multiple myeloma
-
23:23
identifying and treating high-risk patients in 2023
-
7:18
response rate on phase 1/2 trial regn5458 (bcmaxcd3 bispecific antibody) for rrmm patients
-
24:46
sumit verma of iovance biotherapeutics - 1 time therapy for solid tumors
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:52
results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
6:13
phase i study of forimtamig, a gprc5dxcd3 bispecific antibody, in r/r multiple myeloma
-
4:45
a first-in-human trial of regn5458 in r/r myeloma: updated phase i data
-
12:17
updated iv and sc results from a phase i dose escalation study of forimtamig with rrmm patients
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
1:01
car-t: myeloma toxicities
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:44
myeloma qol through induction and maintenance
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl